Validation of the Turkish Translation of the London Speech Evaluation Scale

NCT04690166 | Completed

• 1 other identifier: 462
• Study Type: observational
• Target: 120
• Locations: 1 country
• Sites: 1

Brief Summary

Purpose of the study is the validation and cultual adaptation of the Turkish translation of the London Speech Evaluation Scale (LSE-T), so that it would be used as an assessment tool for Turkish head and neck cancer patients. There is no validated Turkish version of LSE to measure severity of perceptual speech in head and neck cancer patients.

Conditions

Speech Intelligibility; Speech Disorders; Head and Neck Cancer; Speech Dysfunction; Speech

Keywords

Perceptual; speech; articulation; neck; cancer

Outcome Measures

Primary Outcomes (2)

• Validation of the Turkish Translation of London Speech Evaluation Scale

  Turkish Translation of London Speech Evaluation Scale consists of 6 parameters and 4 scores. The minimum score is 0 and maximum score is 24. The lower scores mean a better than high scores.

  Baseline

• Validation of the Turkish Translation of London Speech Evaluation Scale

  Turkish Translation of London Speech Evaluation Scale consists of 6 parameters and 4 scores. The minimum score is 0 and maximum score is 24. The lower scores mean a better than high scores.

  6 weeks

Study Arms (2)

Cancer Patients

In outpatients clinic, the first group consists of 60 head and neck cancer patients who were treated by ours. The participants will given the document consists that "bit, bet, but" words and also a brief part of "Diyet passage" who written by Omer Seyffettin. The speech record of patients who read to document, will evaluated by three judges (otorhinolaryngologist). Three judges will scoring to Turkish translation of London Speech Evaluation Scale (LSE-T), consists of 6 parameters. After the six weeks, the records were scored again as randomisely.

Other: The speech records related to the reading document

Healty Control

In outpatients clinic, the control group consists of 60 patients who have not speech and hear impairments. The participants will given the document consists that "bit, bet, but" words and also a brief part of "Diyet passage" who written by Omer Seyffettin. The speech record of patients who read to document, will evaluated by three judges (otorhinolaryngologist). Three judges will scoring to Turkish translation of London Speech Evaluation Scale (LSE-T), consists of 6 parameters. After the six weeks, the records were scored again as randomisely.

Other: The speech records related to the reading document

Interventions

The speech records related to the reading document OTHER

The document consists "bit, bet, but" words and Diyet passage. Volunteers will read the document in front of the microphone and also the speech will recorded by a computer.

Cancer Patients; Healty Control

Eligibility Criteria

• Age: 18 Years - 70 Years
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Probability Sample

Study Population

Adults with oral, oropharyngeal cancer and healthy adults

You may qualify if:

• Able to speak, read, understand and write in Turkish
• History of oral, orofarengeal cancer
• Volunteers who accept the informed consent

You may not qualify if:

• Mental disorders
• Cognitive limitations
• Able not to speak, read, understand and write in Turkish
• Underwent any surgery last six month
• Permanent tracheostomy, total laryngectomy
• Pregnancy
• Out of age 18-70 years old
• Adults who do not accept the informed consent.

Sponsors & Collaborators

• Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization: lead

Study Sites (1)

Prof Dr Cemil Tascioglu City Hospital

Istanbul, 34384, Turkey (Türkiye)

Location

Related Publications (1)

• Dwivedi RC, Rose SS, Chisholm EJ, Kerawala CJ, Clarke PM, Nutting CM, Rhys-Evans PH, Harrington KJ, Kazi R. Development and validation of first-ever speech-specific perceptual speech evaluation tool for patients with head and neck cancer: the London speech evaluation (LSE) scale. Head Neck. 2012 Jan;34(1):94-103. doi: 10.1002/hed.21683. Epub 2011 Apr 5.

  PMID: 21469245 BACKGROUND

MeSH Terms

Conditions

Speech Intelligibility; Speech Disorders; Head and Neck Neoplasms; Speech; Neoplasms

Condition Hierarchy (Ancestors)

Verbal Behavior; Communication; Behavior; Language Disorders; Communication Disorders; Neurobehavioral Manifestations; Neurologic Manifestations; Nervous System Diseases; Signs and Symptoms; Pathological Conditions, Signs and Symptoms; Neoplasms by Site

Study Officials

• Ziya Salturk, Asso Prof,MD

  Anadolu Medical Center, In Affiliation with Johns Hopkins Medicine

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: OTHER
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Associate Professor, M.D.

Study Record Dates

• First Submitted: December 26, 2020
• First Posted: December 30, 2020
• Study Start: December 21, 2020
• Primary Completion: May 21, 2021
• Study Completion: May 21, 2021
• Last Updated: July 29, 2021

Record last verified: 2021-07

Data Sharing

• IPD Sharing: Will not share

Locations

TU (1)